Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
February 21st, 2024 |
Strengthening Mozambique's Capacity to Integrate and Sustain High-Quality Laboratory Services and Systems under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
February 5th, 2024 |
Strengthening Laboratory Capacity and Quality for HIV Diagnosis, Care, Treatment, and Monitoring in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
February 5th, 2024 |
Implementing Evidence-Based Prevention Interventions for Key and Priority Populations in the Republic of Rwanda under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
February 20th, 2024 |
Strengthening Local and Government Capacity in Mozambique Through Technical Assistance and HIV Service Delivery Support in Zambezia Province in Addition to Targeted National Health Information Systems Strengthening |
Centers for Disease Control CGH |
February 27th, 2024 |
Strengthening Delivery of Quality and Equitable Public Health Services for Prevention, Testing, Care, and Treatment of HIV in Jamaica and Trinidad and Tobago under PEPFAR |
Centers for Disease Control CGH |
February 27th, 2024 |
Improving Integrated Surveillance Methods and Quality of Public Health Systems to Address HIV in Jamaica and Trinidad & Tobago under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
February 20th, 2024 |
Enhance Population Access to Comprehensive HIV/AIDS Services to Achieve HIV/AIDS Epidemic Control in the Democratic Republic of the Congo (DRC), Specifically in Kinshasa Province under the President's Emergency Plan for |
Centers for Disease Control CGH |
January 16th, 2024 |
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) |
National Institutes of Health |
January 25th, 2024 |
Biomedical Research Facilities (C06 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2025 |
Limited Competition: Development and Renovation of Facilities for Expanding the Breeding Capacity of Specific Pathogen Free Non-Human Primates to Support HIV/AIDS-related Research (C06 Clinical Trial Not Allowed) |
National Institutes of Health |
September 25th, 2026 |
National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32) |
National Institutes of Health |
February 21st, 2024 |
Develop, Implement, and Sustain High-Quality Comprehensive Facility and Community-Based HIV 95-95-95 Cascade Activities for Children, Adolescents, and Adults in Cameroon under the President's Emergency Plan for AIDS |
Centers for Disease Control CGH |
February 26th, 2024 |
Strengthening the Government of Lesotho's National and District HIV and TB Programming through Advancing Health Information Systems, Case-Based Surveillance, Monitoring, Evaluation and Quality Improvement Support under |
Centers for Disease Control CGH |
August 14th, 2025 |
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 20th, 2024 |
Targeted Support for Improving HIV Treatment Continuity, Ensuring Availability of Alternate Secure HIV Drug Delivery Points and Services, and Building Capacity of Communities in Haiti under the President's Emergency |
Centers for Disease Control CGH |
February 20th, 2024 |
Enhance Population Access to Comprehensive HIV/AIDS Services to Achieve HIV/AIDS Epidemic Control in the Democratic Republic of the Congo (DRC), Specifically in Haut-Katanga Province under the President's Emergency Plan |
Centers for Disease Control CGH |
February 20th, 2024 |
Building and Improving Integrated Laboratory Capacity and Quality Services in the Democratic Republic of the Congo (DRC) under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
February 20th, 2024 |
Expansion of Community HIV Response in Nigeria through Civil Society Organizations under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 19th, 2025 |
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional) |
National Institutes of Health |
December 5th, 2023 |
Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
|
December 5th, 2023 |
Pre-Cancer Atlas (PCA) Research Centers (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
December 5th, 2023 |
Single Source: Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC; U24 Clinical Trial Not Allowed) |
National Institutes of Health |
March 13th, 2026 |
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) |
National Institutes of Health |
December 1st, 2023 |
Career Enhancement Award to Advance the Study of Intimate Partner Violence (IPV) in the Context of Maternal Morbidity and Mortality Research (K18 Clinical Trial Not Allowed) |
National Institutes of Health |
December 1st, 2023 |
R25 for Short Courses on Techniques for Measuring Intimate Partner Violence (IPV) in Different Populations (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
March 4th, 2024 |
Health Promotion and Disease Prevention Research Centers: 2024 Special Interest Project Competitive Supplements (SIPS) |
Centers for Disease Control and Prevention ERA |
February 20th, 2024 |
Network of Community Cohorts for Monitoring Changes in Respiratory Virus Epidemiology (Pandemic Preparedness Cohorts) |
Centers for Disease Control and Prevention ERA |
February 16th, 2024 |
Nationwide Cohort to Estimate Burden of Respiratory Viruses and Immunologic Response (Blood Donor Cohort) |
Centers for Disease Control and Prevention ERA |
February 22nd, 2024 |
Clinical and Public Health Curriculum Development, Training, Mentoring, and Implementation of Continuous Quality Improvement for the Haitian Healthcare System under the President's Emergency Plan for AIDS Relief |
Centers for Disease Control CGH |
March 4th, 2024 |
Strengthening Capacity of Central Asia and Eastern Europe Countries to Implement Sustainable and Effective HIV/AIDS Prevention, Care, and Treatment and Health Security Programs under PEPFAR |
Centers for Disease Control CGH |
April 12th, 2024 |
Screening, Brief Intervention, and Referral to Treatment (SBIRT) |
Substance Abuse and Mental Health Services Adminis |
May 7th, 2027 |
Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed) |
National Institutes of Health |
January 29th, 2026 |
Advancing Research Careers (ARC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2027 |
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
August 14th, 2026 |
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Basic Experimental Studies with Humans Required) |
National Institutes of Health |
August 14th, 2026 |
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
August 14th, 2026 |
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required) |
National Institutes of Health |
August 14th, 2026 |
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional) |
National Institutes of Health |
March 13th, 2026 |
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
March 13th, 2026 |
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) |
National Institutes of Health |